Overview

Selective Microbiota Transplantation for Tourette's Syndrome

Status:
Unknown status

Trial end date:
2020-10-31

Target enrollment:
0

Participant gender:
All

Summary

This study aimed to evaluate the role of selective microbiota transplantation on Tourette's syndrome (TS).

Phase:

Phase 1/Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Faming Zhang

Criteria

Inclusion Criteria:

- 7-60 years old with Tourette or chronic tic disorder of moderate or greater severity
as measured by a Yale Global Tic Severity Scale-Total score>25

Exclusion Criteria:

- Complicated with certain brain disease, including tumor,injury,cerebrovascular
disease;

- Complicated with other severe disease, including cancers, organ failure, heart
diseases;

- Follow-up less than 8 weeks.